Skip to Main Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know:

Get the latest public health information from CDC:

Get the latest research information from NIH:

Here you can browse the complete list of projects on CDAS whose requests for data/biospecimens were approved.

Data-Only Studies
Biospecimen Studies
Name Principal Investigator Institution Study Date Approved Project ID
Genetic Variants of Dopamine Receptors and Smoking Neil Caporaso NCI, DCEG, GEB PLCO Jul 1, 2006 2006-0047
Epidemiology of CA-125 Christine Johnson Henry Ford Health System PLCO Jul 1, 2006 2006-0003
Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results from the Baseline Screening Examination. Joel Weissfeld University of Pittsburgh PLCO Jul 1, 2006 2006-0264
Overview of Trends from Repeated PSA Screening for Prostate Cancer: Report from the PLCO Cancer Screening Trial (The next results of screening Post T0 Paper using T0-T3 data) Gerald Andriole Washington University in St. Louis PLCO Jul 1, 2006 2006-0031
A Case/Control Study of Polymorphisms in Cyclooxygenases Involved in Arachidonic Acid Pathway in Colorectal Adenomas Iqbal Ali NCI, DCP, LCP PLCO Jul 1, 2006 2006-0027
Recruitment Across 10 Screening Centers Lois Lamerato Henry Ford Health System PLCO Jul 1, 2006 2006-0164
AAMEN Study Outcomes Marvella Ford Medical University of South Carolina Hollings Cancer Center PLCO Jul 1, 2006 2006-0091
Study of Effectiveness of Computer Aided Detection of Missed Cancers Matthew Freedman Georgetown University PLCO Jul 1, 2006 2006-0095
Willingness of Study Subjects to Provide Biological Specimens to be Stored for Future Research Christine Johnson Henry Ford Health System PLCO Jul 1, 2006 2006-0157
Who Participates in Clinical Trials Lois Lamerato Henry Ford Health System PLCO Jul 1, 2006 2006-0162
The Association of Family History and SES with Advanced/Aggressive Prostate Tumors in PLCO Robert Greenlee Marshfield Clinic Research Foundation PLCO Jul 1, 2006 2006-0113
BPH-Behavioral Factors Daehee Kang NCI, DCEG, OEEB PLCO Jul 1, 2006 2006-0006
Serum Protein Markers of Early Oncogenic Events: A Pre-Diagnostic Study of Multiple Myeloma Ola Landgren NCI, DCEG, GEB PLCO Jun 7, 2006 2005-0017
Functional DNA Repair Assays for Lung Cancer Risk: Prospective Analysis Alice Sigurdson NCI PLCO May 17, 2006 2005-0013
Alcohol intake, genes responsible for alcohol metabolism, and risk of breast cancer in the PLCO cohort Catherine McCarty Marshfield Clinic Research Foundation PLCO Apr 21, 2006 2005-0027
Chlamydia pneumoniae infection, chronic inflammation and risk of lung cancer Anil Chaturvedi NCI, DCEG, IIB PLCO Apr 21, 2006 2005-0014
Serum 25-hydroxyvitamin D, dietary vitamin D and non-Hodgkin Lymphoma: a Nested Case Control Study in the PLCO Trial Mark Purdue NCI, DCEG, OEEB PLCO Apr 21, 2006 2005-0021
Measuring carcinogen metabolite levels in long-term smokers and estimating the risk of lung cancer Timothy Church University of Minnesota PLCO Apr 21, 2006 2005-0029
Genetic variation in the vitamin E blood transport, cellular uptake, and metabolism pathway and prostate cancer risk Demetrius Albanes Extramural PLCO Apr 21, 2006 2005-0018
Biomarkers and genetic polymorphisms of one-carbon metabolism and risk of lymphoid cancers Unhee Lim NCI, DCEG, NEB PLCO Apr 21, 2006 2005-0025